|
sars-cov-2 |
26 |
|
covid-19 |
17 |
|
influenza |
16 |
|
humans |
14 |
|
mers-cov |
14 |
|
coronavirus |
13 |
|
animals |
12 |
|
africa |
11 |
|
transmission |
11 |
|
acute lung injury |
10 |
|
adaptor proteins, signal transducing - genetics - immunology - metabolism |
10 |
|
birds |
10 |
|
cells, cultured |
10 |
|
chemicals and cas registry numbers |
10 |
|
cyclooxygenase 2 - biosynthesis - genetics |
10 |
|
cyclooxygenase 2 inhibitors |
10 |
|
cytokines - metabolism |
10 |
|
dead-box rna helicases - genetics - immunology - metabolism |
10 |
|
epithelial cells - immunology - metabolism |
10 |
|
h7n9 |
10 |
|
immunity, innate |
10 |
|
influenza a virus, h1n1 subtype - genetics - immunology |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology |
10 |
|
influenza a virus, h5n1 subtype - genetics - immunology - pathogenicity |
10 |
|
influenza in birds - enzymology - immunology - virology |
10 |
|
influenza, human - enzymology - virology |
10 |
|
influenza, human - immunology - metabolism - virology |
10 |
|
interferon regulatory factor-3 - metabolism |
10 |
|
janus kinases - immunology |
10 |
|
macrophages - immunology - metabolism |
10 |
|
mesenchymal stromal cells |
10 |
|
nf-kappa b - metabolism |
10 |
|
p38 mitogen-activated protein kinases - metabolism |
10 |
|
paracrine communication - immunology |
10 |
|
pulmonary alveoli - immunology - metabolism |
10 |
|
receptor, interferon alpha-beta - immunology |
10 |
|
rna, small interfering - genetics |
10 |
|
rna, viral - metabolism |
10 |
|
signal transduction |
10 |
|
toll-like receptor 3 - metabolism |
10 |
|
up-regulation |
10 |
|
alveolar fluid clearance |
9 |
|
avian |
9 |
|
alveolar epithelial cells |
8 |
|
autopsy |
8 |
|
characterization |
8 |
|
china |
8 |
|
coronaviruses |
8 |
|
hong kong |
8 |
|
phenotype |
8 |
|
bronchial tissue |
7 |
|
evolution |
7 |
|
h5n1 |
7 |
|
mers |
7 |
|
nasal tissue |
7 |
|
omicron ba.2 |
7 |
|
pathogenicity |
7 |
|
sars |
7 |
|
zoonosis |
7 |
|
airway epithelial cells |
6 |
|
cigarette smoking |
6 |
|
dogs |
6 |
|
ex vivo |
6 |
|
explants |
6 |
|
hpai |
6 |
|
nsp6 |
6 |
|
risk assessment |
6 |
|
sars-cov |
6 |
|
virus evolution |
6 |
|
clade 2.3.4.4 |
5 |
|
cyclosporine |
5 |
|
emetine |
5 |
|
ex vivo explants |
5 |
|
fomite |
5 |
|
hpai h5nx |
5 |
|
lopinavir |
5 |
|
middle east respiratory syndrome coronavirus (mers-cov) |
5 |
|
remdesivir |
5 |
|
ritonavir |
5 |
|
type i interferon |
5 |
|
amino acid sequence |
4 |
|
caveolin 1 - metabolism |
4 |
|
conjunctiva |
4 |
|
coronavirus disease 2019 |
4 |
|
coronavirus infections |
4 |
|
cytokine |
4 |
|
cytokines |
4 |
|
eye tissue |
4 |
|
farnesyl transferase inhibitor |
4 |
|
hajj |
4 |
|
human |
4 |
|
immunohistochemistry |
4 |
|
influenza a virus |
4 |
|
innate sensing receptors |
4 |
|
middle east respiratory syndrome coronavirus |
4 |
|
rig-i |
4 |
|
sars virus - metabolism |
4 |
|
statin |
4 |
|
sterol biosynthesis |
4 |
|
tlr3 |
4 |
|
viral structural proteins - metabolism |
4 |
|
zometa |
4 |
|
immunity, innate - physiology |
3 |
|
influenza a virus - isolation & purification |
3 |
|
influenza a virus, h1n1 subtype - immunology |
3 |
|
influenza a virus, h5n1 subtype |
3 |
|
influenza a virus, h5n1 subtype - immunology |
3 |
|
influenza in birds - immunology - prevention and control |
3 |
|
influenza, human - immunology - prevention and control |
3 |
|
orthomyxoviridae infections - pathology - transmission - veterinary |
3 |
|
swine |
3 |
|
swine diseases - pathology - virology |
3 |
|
cancer cells. |
2 |
|
cellular signal transduction. |
2 |
|
chemokines. |
2 |
|
immunosuppression. |
2 |
|
influenza a virus. |
2 |
|
leukemia - chemotherapy. |
2 |
|
macrophages. |
2 |
|
polyporaceae. |
2 |
|
polysaccharides. |
2 |
